Wolters Kluwer and Bridgepoint Reach Agreement on Sale of Education: see www.wolterskluwer.com
March 26, 2007 02:00 ET
|
Wolters Kluwer N.V.
For release content, please refer to the attachment....
Share quantities in BALTIX for Q2 2007
March 26, 2007 01:59 ET
|
Nasdaq Riga
According to BALTIX index calculation methodology the indexed share quantities
are determined on a quarterly basis on March 15, June 15, September 15, and
December 15 and applied respectively...
Proposal of the Board to the shareholders meeting concerning payment of dividends
March 26, 2007 01:51 ET
|
Lietuvos Energija AB
The Board of Directors of Lietuvos Energija AB (company code 220551550)
proposes to the General Meeting of Shareholders to pay dividends to the
shareholders of the company in the amount of LTL 8,15...
Maksuttomassa osakeannissa annettavat osakkeet rekisteröity
March 26, 2007 01:28 ET
|
Julius Tallberg-Kiinteistöt Oyj
Julius Tallberg-Kiinteistöt Oyj PÖRSSITIEDOTE
26.3.2007
MAKSUTTOMASSA OSAKEANNISSA ANNETTAVAT OSAKKEET...
Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
March 26, 2007 01:15 ET
|
Novartis Pharma AG
A Novartis-branded version of interferon beta-1b to be launched in first half 2009
Move strengthens Novartis multiple sclerosis (MS) portfolio ahead of on-track submission in 2009 of once-daily...
Novartis va lancer, sous sa propre marque, une thérapie de pointe contre la sclérose en plaques par le biais d'un accord avec Bayer Schering Pharma
March 26, 2007 01:15 ET
|
Novartis Pharma AG
Novartis va lancer sous sa propre marque une version de l'interféron bêta-1b au premier semestre 2009
Cette initiative renforce le portefeuille de traitements de la sclérose en plaques (SEP)...
Novartis vereinbart mit Bayer Schering Pharma die Vermarktung eines führenden Medikaments gegen Multiple Sklerose unter eigenem Namen
March 26, 2007 01:15 ET
|
Novartis Pharma AG
Novartis plant Markteinführung einer eigenen Version von Interferon Beta-1b in der ersten Hälfte des Jahres 2009
Transaktion stärkt das Portfolio von Novartis im Bereich Multiple Sklerose noch...
ELEKTROBIT ALENTAA ENSIMMÄISEN VUOSIPUOLISKON 2007 LIIKEVAIHTO- JA
LIIKEVOITTOENNUSTETTA
March 26, 2007 01:00 ET
|
Bittium Oyj
Julkaisuvapaa 26. maaliskuuta 2007 kello 8.00
ELEKTROBIT ALENTAA ENSIMMÄISEN VUOSIPUOLISKON 2007 LIIKEVAIHTO- JA
LIIKEVOITTOENNUSTETTA
Elektrobit odottaa vuoden 2007 ensimmäisen ...
ELEKTROBIT LOWERS THE REVENUE AND OPERATING PROFIT FORECASTS FOR THE
FIRST HALF OF 2007
March 26, 2007 01:00 ET
|
Bittium Oyj
Free for publication on March 26, 2007 at 8.00 am. (EET)
ELEKTROBIT LOWERS THE REVENUE AND OPERATING PROFIT FORECASTS FOR THE
FIRST HALF OF 2007
Elektrobit expects the revenue during the first...
Kallelse till ordinarie bolagsstämma (årsstämma) i Teleca AB (publ)
March 26, 2007 01:00 ET
|
Teleca AB
Kallelse till ordinarie bolagsstämma (årsstämma) i Teleca AB (publ)
Aktieägarna i Teleca AB (publ) kallas härmed till årsstämma tisdagen den 24
april 2007 kl 17.00 i Börshuset, Skeppsbron 2, Malmö....
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California